93 results on '"Brook C"'
Search Results
2. Bat conservation and zoonotic disease risk: a research agenda to prevent misguided persecution in the aftermath of COVID‐19
3. Habitat diversification tactic for improving biological control: parasitism of the western grape leafhopper
4. Disc heating: comparing the Milky Way with cosmological simulations
5. The origin of the light distribution in spiral galaxies
6. Risk-based decision-making for blood safety: preliminary report of a consensus conference
7. ChemInform Abstract: Syntheses of Strychnos- and Aspidospermatan-Type Alkaloids. Part 5. Total Syntheses of (.+-.)-Echitamidine and 20-epi- and 19-epi-20-epi- Echitamidine.
8. ChemInform Abstract: Total Syntheses of Strychnos Alkaloids.
9. ChemInform Abstract: Syntheses of Strychnos- and Aspidospermatan-Type Alkaloids. Part 6. Total Syntheses of (.+-.)-Echitamidine, (.+-.)-Alstogustine, (.+-.)-19- epi-Alstogustine, and (.+-.)-Akuammicine.
10. ChemInform Abstract: Spongistatin Synthetic Studies. Part 1. Construction of a C(29-48) Subtarget.
11. ChemInform Abstract: Spongistatin Synthetic Studies. Part 3. Construction of the C(1-17) Spiroketal.
12. ChemInform Abstract: Spongistatin Synthetic Studies. Part 2. Assembly of the C(18-28) Spiroketal.
13. Residential Experience in Psychiatric Hospitals for Medical Students
14. Clinical tutors in psychiatry
15. Prediction of Adult Stature
16. Gastric acid secretory capacity falls after repeated within-day pentagastrin testing in fed subjects
17. Frasier syndrome, part of the Denys Drash continuum or simply a WT1 gene associated disorder of intersex and nephropathy?
18. The relative roles of continuous growth hormone-releasing hormone (GHRH(1-29)NH2 ) and intermittent somatostatin(1-14)(SS) in growth hormone (GH) pulse generation: studies in normal and post cranial irradiated individuals
19. Peak and trough growth hormone (GH) concentrations influence growth and serum insulin like growth factor-1 (IGF-1) concentrations in short children
20. Growth in children with craniopharyngioma following surgery
21. Gonadotrophin pulsatility in girls with the Turner syndrome: modulation by exogenous sex steroids
22. Habitat diversification tactic for improving biological control: parasitism of the western grape leafhopper
23. The effect of initial dose of thyroxine in congenital hypothyroidism on final height
24. Final height in non‐growth hormone deficient children
25. Re‐use of electrode catheters labelled as single use
26. Growth hormone replacement treatment in adult patients
27. GH responses to intravenous bolus infusions of GH releasing hormone and GH releasing peptide 2 separately and in combination in adult volunteers
28. Short stature and growth hormone deficiency
29. The growth and cardiovascular effects of high dose growth hormone therapy in idiopathic short stature
30. Precocious puberty
31. The effect of a continuous infusion of a somatostatin analogue (octreotide) for two years on growth hormone secretion and height prediction in tall children
32. The consequences of congenital hypothyroidism
33. The relationship between endogenous testosterone and gonadotrophin secretion
34. The effects of oxandrolone on the growth hormone and gonadal axes in boys with constitutional delay of growth and puberty
35. Blood pressure and the renin-angiotensin-aldosterone system in children receiving recombinant human growth hormone
36. Analysis of trough serum growth hormone concentrations: comparison of an immunoradiometric assay and a sensitive ELISA for growth hormone
37. Suicide and community psychiatric care — a preliminary report
38. Rate of change (modulation) of serum growth hormone concentrations is a more important factor in determining growth rate than duration of exposure
39. The interaction of growth hormone releasing hormone and somatostatin in the generation of a GH pulse in man
40. A distribution method for analysing the baseline of pulsatile endocrine signals as exemplified by 24‐hour growth hormone profiles
41. Reproducibility of 24-hour serum growth hormone profiles in man
42. Wider indications for treatment with biosynthetic human growth hormone in children
43. Growth characteristics and response to growth hormone therapy in patients with hypochondroplasia: genetic linkage of the insulin-like growth factor I gene at chromosome 12q23 to the disease in a subgroup of these patients
44. The pituitary gland is capable of responding to two successive doses of growth hormone releasing hormone (GHRH)
45. Management of Growth Hormone Deficiency Through Puberty
46. CURRENT THERAPY THE MANAGEMENT OF CLASSICAL CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY
47. Growth and Growth Hormone Secretion in Children Following Treatment of Brain Tumours with Radiotherapy
48. THE INTERACTION BETWEEN CLONIDINE AND GROWTH HORMONE RELEASING HORMONE IN THE STIMULATION OF GROWTH HORMONE SECRETION IN MAN
49. Growth and Growth Hormone Therapy in Hypochondroplasia
50. THE APPLICATION OF DECONVOLUTION ANALYSIS TO ELUCIDATE THE PULSATILE NATURE OF GROWTH HORMONE SECRETION USING A VARIABLE HALF‐LIFE OF GROWTH HORMONE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.